Výsledky vyhledávání - "Séverine, Brillouet"

Akademický článek

Impact of different models based on blood samples and images for bone marrow dosimetry after 177Lu-labeled somatostatin-receptor therapy

Autor: Delphine Vallot, Séverine Brillouet, Séléna Pondard, Lavinia Vija, Jean-Sébastien Texier, Lawrence Dierickx, Frédéric Courbon

Publikováno v: EJNMMI Physics, Vol 11, Iss 1, Pp 1-13 (2024)

Abstract Background Peptide receptor radionuclide therapy with 177Lu-DOTATATE is a recognized option for treating neuroendocrine tumors and has few toxicities, except for the kidneys and bone marrow. The bone marrow dose is generally derived from a S

Externí odkaz: https://doaj.org/article/f9bf2df61d2640009f45d2555143bb99

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Insertion of synthetic lesions on patient data: a method for evaluating clinical performance differences between PET systems

Autor: Quentin Maronnier, Nesrine Robaine, Léonor Chaltiel, Lawrence O. Dierickx, Thibaut Cassou-Mounat, Marie Terroir, Lavinia Vija, Delphine Vallot, Séverine Brillouet, Chloé Lamesa, Thomas Filleron, Olivier Caselles, Frédéric Courbon

Publikováno v: EJNMMI Physics, Vol 11, Iss 1, Pp 1-14 (2024)

Abstract Background Performance assessment of positron emission tomography (PET) scanners is crucial to guide clinical practice with efficiency. We have already introduced and experimentally evaluated a simulation method allowing the creation of a co

Externí odkaz: https://doaj.org/article/7196d41f870a4e0a8f7f270bbc38876e

Zobrazit plný text záznamu

Plný text ve formátu HTML

Supplementary Data from Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer

Autor: Ben C. Allal, Frédéric Courbon, Pierre Canal, Séverine Brillouet, Thomas Filleron, Olivier Caselles, Philippe Rochaix, Fabienne Thomas, Jean-Pierre Delord, Sébastien Vergez

Supplementary Figure S1 and Supplementary Table S1.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dba6a0b4083fdc3ccfd8c0e0f8a2df2
https://doi.org/10.1158/1078-0432.22441755.v1

Zobrazit plný text záznamu

Data from Preclinical and Clinical Evidence that Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography with Computed Tomography Is a Reliable Tool for the Detection of Early Molecular Responses to Erlotinib in Head and Neck Cancer

Autor: Ben C. Allal, Frédéric Courbon, Pierre Canal, Séverine Brillouet, Thomas Filleron, Olivier Caselles, Philippe Rochaix, Fabienne Thomas, Jean-Pierre Delord, Sébastien Vergez

Purpose: There is a clinical need to identify predictive markers of the responses to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKI). Deoxy-2-[18F]fluoro-d-glucose positron emission tomography with computed tomography (18FDG-PE

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5960a15a7b27053530620cf85c3e1a2d
https://doi.org/10.1158/1078-0432.c.6518691

Zobrazit plný text záznamu

Comparison of Two Types of Amino Acid Solutions on 177Lu-Dotatate Pharmacokinetics and Pharmacodynamics in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Autor: Etienne Chatelut, Marie Lambert, Lawrence Dierickx, Séverine Brillouet, Frédéric Courbon

Publikováno v: Current Radiopharmaceuticals. 15:164-172

Background: 177Lu-Dotatate is used in the treatment of somatostatin-receptor-positive inoperable progressive gastroenteropancreatic neuroendocrine tumors. A co-infusion of amino acids (AAs) is administered to prevent renal toxicity. Objective: This s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0a2f5534afb14b45ea56819b94adb9b1
https://doi.org/10.2174/1874471015666211228123525

Zobrazit plný text záznamu

Comparison of Two Types of Amino Acid Solutions on

Autor: Marie, Lambert, Lawrence, Dierickx, Séverine, Brillouet, Frédéric, Courbon, Etienne, Chatelut

Publikováno v: Current radiopharmaceuticals. 15(2)

This study aimed to quantify the impact of two types of AA cocktails on the pharmacokinetics and toxicity ofFour injections of 7400 MBq1,678Unlike Primene®, Lysakare® does not increase

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::2954aa09321634f2287338b953728ca0
https://pubmed.ncbi.nlm.nih.gov/35105299

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Successful and Safe Treatment With 177Lu-DOTATATE (Lutathera) of Progressive Metastatic Pancreatic Neuroendocrine Tumor Under Hemodialysis.

Autor: Dierickx, Lawrence O., Séverine, Brillouet, Fatima, Mokrane, Amel, Bensafi, Rosine, Guimbaud

Publikováno v: Clinical Nuclear Medicine; Sep2020, Vol. 45 Issue 9, pe400-e402, 3p

Zobrazit plný text záznamu

Optimization of the radiobiological effect for peptide receptor radionuclide therapy of neuroendocrine tumors

Autor: Rossetto, Nicolas

Publikováno v: Imagerie médicale. Université Paul Sabatier-Toulouse III, 2017. Français. ⟨NNT : 2017TOU30223⟩

Les médicaments radiopharmaceutiques ciblant les récepteurs peptidiques tels que les analogues de la somatostatine ont un réel potentiel et un fort intérêt pour à la fois le diagnostic et le traitement des tumeurs neuroendocrines (TNE) non-opé

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1398::cb0aa395e0fde5851187988c1504c7b0
https://theses.hal.science/tel-03667321

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání